RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 47 filers reported holding RELMADA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,922,246 | +36.0% | 974,082 | +11.5% | 0.23% | +40.9% |
Q2 2023 | $2,148,348 | +31.6% | 873,312 | +20.9% | 0.16% | +25.2% |
Q1 2023 | $1,632,096 | -5.8% | 722,166 | +45.5% | 0.13% | -9.7% |
Q4 2022 | $1,731,926 | -90.7% | 496,254 | -1.5% | 0.14% | -91.3% |
Q3 2022 | $18,651,000 | +95.0% | 503,801 | +0.0% | 1.67% | +94.7% |
Q2 2022 | $9,567,000 | -29.5% | 503,776 | +0.1% | 0.86% | -16.2% |
Q1 2022 | $13,578,000 | +19.7% | 503,076 | -0.1% | 1.03% | +26.2% |
Q4 2021 | $11,342,000 | -8.5% | 503,412 | +6.4% | 0.81% | -16.1% |
Q3 2021 | $12,397,000 | -14.0% | 472,974 | +5.0% | 0.97% | -12.1% |
Q2 2021 | $14,418,000 | -9.3% | 450,412 | -0.2% | 1.10% | -15.2% |
Q1 2021 | $15,894,000 | +9.7% | 451,412 | -0.0% | 1.30% | +4.2% |
Q4 2020 | $14,483,000 | -15.4% | 451,612 | -0.8% | 1.25% | -25.3% |
Q3 2020 | $17,122,000 | -15.7% | 455,137 | +0.2% | 1.67% | -22.8% |
Q2 2020 | $20,320,000 | +40.0% | 454,087 | +6.7% | 2.16% | +15.7% |
Q1 2020 | $14,516,000 | +1.4% | 425,575 | +16.0% | 1.87% | +30.2% |
Q4 2019 | $14,310,000 | – | 366,933 | – | 1.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
Savior LLC | 3,500 | $10,500 | 0.07% |
Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |